Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-042728

Chief Medical Officer sold 45,316 shares at $8.76 ($396,995)

  • Chief Medical Officer acquired 18,489 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nichols William Garrett Chief Medical Officer 2025-03-18 Option exercise 10b5-1 +4,584 $3.75 $17,190 83,904 D
Nichols William Garrett Chief Medical Officer 2025-03-18 Option exercise 10b5-1 +13,905 $1.29 $17,937 97,809 D
Nichols William Garrett Chief Medical Officer 2025-03-18 Sale 10b5-1 −45,316 $8.76 $396,995 52,493 D
Derivatives
Nichols William Garrett Chief Medical Officer 2025-03-18 Option exercise · Stock Option (Right to Buy) 10b5-1 −4,584 195,416 D
Nichols William Garrett Chief Medical Officer 2025-03-18 Option exercise · Stock Option (Right to Buy) 10b5-1 −13,905 31,095 D
Open-market sales · 45,316 sh · avg $8.76 · $396,995
Loading xslF345X05/ownership.xml…